Renal Cancer

Updates and controversies in contemporary grading of clear cell renal cell carcinoma and papillary renal cell carcinoma. June 5, 2026

Outcomes of Complete Responders From First-line Therapy in Metastatic Renal Cell Carcinoma in the Real World: An Analysis From the International Metastatic Renal Cell Carcinoma Database Consortium - Beyond the Abstract June 4, 2026

Cancer-Associated Fibroblasts Promote Development of Papillary Renal Cell Carcinoma by Inducing Histone Lactylation of RBM15B to Modify in an m6A-Dependent Manner on ANLN. June 4, 2026

Survival Trends in Metastatic Renal Cell Carcinoma Across Therapeutic Eras and Histologic Subtypes. June 3, 2026

Should Metastatic Site Inform First-Line Therapy in Clear Cell Renal Cell Carcinoma? June 2, 2026

Sex-Specific Adverse Events and Cardiovascular Toxicity of Cabozantinib in Renal Cell Carcinoma: A Nine-Year Pharmacovigilance Study. June 1, 2026

Natural Products in Clear Cell Renal Cell Carcinoma: Rewiring the VHL-HIF Axis, Metabolic Plasticity, and Tumor-Immune Interactions. May 29, 2026

Histologic Heterogeneity of Metastases in Clear Cell Renal Cell Carcinoma with Sarcomatoid Differentiation. May 28, 2026

Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial. May 27, 2026

Two decades of research on drug resistance in renal cell carcinoma. May 26, 2026

Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-invasive Bladder Cancer. June 5, 2026

Sutureless Robotic-Assisted Partial Nephrectomy: A Propensity Score-Matched Analysis (UroCCR N.158) - Beyond the Abstract June 4, 2026

Comparative effectiveness and cost-effectiveness of an artificial intelligence workflow for small renal mass diagnosis on computed tomography. June 4, 2026

Co-overexpression of ELOVL2 and ELOVL5 promotes clear cell renal cell carcinoma progression through LIMK1-mediated cytoskeletal reorganization. June 3, 2026

Percutaneous thermal ablation versus robot-assisted partial nephrectomy for localized renal cell carcinoma: a systematic review and meta-analysis stratified by tumor complexity. June 2, 2026

Bayesian Evaluation of Treatment Effect of Avelumab Plus Axitinib for Advanced Renal Cell Carcinoma. June 1, 2026

Joint effects and dynamic trajectories of metabolic insulin resistance and systemic inflammation in the risk of renal cell carcinoma: a UK Biobank cohort analysis. May 29, 2026

Metastatic Patterns and Adverse Histopathologic Features in Advanced Renal Cell Carcinoma: A Five-Year Single-Center Retrospective Pathology Study. May 28, 2026

Overdiagnosis in renal cancer: the hidden consequence of modern imaging. May 27, 2026

Improving Clear Cell Renal Cell Carcinoma Diagnosis: Modified CT Algorithms with Simplified Heterogeneity Scoring. May 26, 2026

Page 1 of 517